Staphylococcus aureus, VISA/VRSA

TEST NAME Staphylococcus aureus (VISA/VRSA)
DISEASE/DISORDER Bacteremia, pneumonia, skin infections, surgical site infections
ALTERNATE NAME(S)

S.aureus, Vancomycin intermediate Staphylococcus aureus, Vancomycin

resistant Staphylococcus aureus, VISA, VRSA
METHODOLOGY Culture
SPECIAL INSTRUCTIONS

CEDEP approval required prior to isolate submission.
ORDERING INFORMATION TDH DLS Requisition:  PH-4182 Clinical Submission Requisition

Specimen Requirements

Patient Preparation
  • None
Specimen Collection
  • Isolate: Pure cultures
Specimen Labeling
  • Specimen must be labeled with at least two unique patient identifiers and match accompanying PH-4182 Clinical Submission Requisition.
Specimen Processing
  • None
Specimen Storage and Preservation
  • Isolates should be stored at ambient conditions.
Specimen Transport
  • Ship isolates in ambient conditions.
  • Do not send isolates refrigerated or frozen.
  • All infectious substance shipments must conform to U.S. Department of Transportation (DOT) Hazardous Materials Regulations (HMR 49 C.F.R. Parts 171-180). 
Specimen Acceptability and Rejection
  • Specimens that do not adhere to all specimen requirements will be rejected.
Testing Location
  • Nashville

This Page Last Updated: February 28, 2026 at 10:34 PM